$149M&A Pre-Acquisition Check — Protect millions before you sign. Instant report.Run a Check →

AI Lead Evaluation — Fast Track

This tool provides a rapid, structured assessment of AI-generated or computationally-derived drug leads. Results are for informational purposes only and do not constitute scientific, medical, legal, or regulatory advice.

Important: Do not enter compound names, SMILES strings, CAS numbers, or any proprietary identifiers. Describe your program in general scientific terms only. Bridge BioHealth does not store any submitted data.

AI Lead Fast-Track 3 Steps · ~5 Minutes Anonymized

AI Lead Evaluation
Fast-Track Assessment

A streamlined 3-step Go/No-Go evaluation purpose-built for AI-generated molecules, virtual screening hits, generative model outputs, and computationally-derived leads. Evaluate the evidence, not the algorithm.

Model Confidence ScoringAccounts for AI confidence scores

Validation Gap AnalysisFlags unconfirmed predictions

IP Risk AssessmentAI-specific prior art considerations

5-Minute CompletionStreamlined vs. full 6-step tool

AI/Computational Context

Experimental Validation

Readiness & Risks

Step 1: AI/Computational Context

Step 1 of 3

Project Alias / Code Name

Therapeutic Area

AI / Computational Method

Modality

Training Data Quality

Model Confidence Score (%)

Enter the model's predicted confidence or docking score percentile (0–100)

Target Class

No identifiers needed No data stored ~5 minutes to complete